Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Bond Issue

30 Jun 2014 17:55

RNS Number : 9884K
Phoenix Group Holdings
30 June 2014
 



This announcement is not for release in the United States of America, Canada, Australia, South Africa and Japan or in any other jurisdiction in which offers or sales would be prohibited by applicable law.

 

30 June 2014

 

Phoenix Group announces a ÂŁ300 million senior unsecured bond issue

 

Highlights

 

· Priced a £300 million 7 year Sterling-denominated senior unsecured bond at an annual coupon of 5.75%

· Strong demand from fixed income institutional investors following a three day investor roadshow

· Proceeds will be used to refinance a portion of the Group's existing Impala silo senior bank debt

· Supports Phoenix's plans to unify the two existing bank debt facilities into a single facility

· Phoenix continues to target an investment grade credit rating

 

Summary of transaction

 

Phoenix Group Holdings ("Phoenix" and, together with its subsidiaries, the "Group") announces that it has priced a ÂŁ300 million 7 year Sterling denominated senior unsecured bond (the "Bond"). The Bond will be issued by PGH Capital Limited, a financing subsidiary of Phoenix Group Holdings, and guaranteed by Phoenix. The Bond will be issued on 7 July 2014 with a maturity date of 7 July 2021.

 

The successful Bond issue is a further milestone in the financial strengthening of Phoenix and an important step towards gaining wider access to the debt capital markets as it seeks to further simplify the Group's debt structure. The net proceeds from the issue will be used to refinance part of the Group's existing Impala silo senior bank debt1.

 

The transaction saw strong demand from fixed income institutional investors with an order book that was two times over-subscribed and enabling Phoenix to price the Bond at the bottom of its target range, with the annual coupon being 5.75%.

 

In addition to re-financing a proportion of the Group's existing Impala silo bank debt, the transaction is expected to provide greater financial flexibility for the Group in future, including:

 

· Reducing the Group's reliance on bank finance by accessing the wider debt capital markets, thereby reducing the refinancing requirement from Phoenix's existing bank debt structure;

· Extending the maturity profile of the Group's debt, with the term of the Bond being two years longer than the final maturity of the existing Impala bank facility in June 2019, thereby better matching the debt amortisation profile to Phoenix's forecast cash generation;

· Reducing interest costs for the Group, with an annual coupon of 5.75% on the Bond (with the re-offer yield equivalent to 7 year Sterling mid-swaps plus 321bps). This coupon compares favourably to the margin of the current Impala bank facility which is currently 475bps, with a step up in margin to 700bps above Libor from 1 January 2018;

· Further supporting Phoenix's sustainable dividend policy and generating additional financial flexibility for the Group to participate in future consolidation of the UK closed life fund market;

· Facilitating Phoenix's plans to unify the two existing bank debt facilities into a single facility, simplifying the corporate structure and facilitating a possible future internal merger of the Group's two largest UK life companies; and

· Offering Phoenix an additional source of funding as it implements its growth strategy of closed life fund consolidation, as well as enhancing Phoenix's credibility as a counterparty.

 

Furthermore, Phoenix continues to target an investment grade credit rating and expects to engage with rating agencies in due course.

 

Citigroup, HSBC, J.P. Morgan Cazenove and Lloyds Bank are acting as joint lead managers on the transaction2.

 

Clive Bannister, Group Chief Executive, commented:

 

"This successful debut Bond issue is another step in the strengthening of the Phoenix Group. The Bond issue, together with the other actions that Phoenix has taken over the past 18 months, will have allowed us to reduce our bank debt since the start of 2013 from ÂŁ2.3 billion to ÂŁ1.0 billion. This issue demonstrates Phoenix's ability to access the wider debt capital markets on attractive terms, extending the maturity profile of our debt and providing the Group with additional flexibility in executing its growth strategy. Furthermore, it provides a base from which we will continue to progress our aims of unifying our two bank debt silos and ultimately seeking an investment grade credit rating."

 

 

Enquiries

 

Equity Investors:

Sam Perowne, Head of Investor Relations, Phoenix Group

+44 (0) 20 3735 0021

 

Debt Investors:

Rashmin Shah, Group Treasurer, Phoenix Group

+44 (0) 20 3735 0059

 

Media:

Neil Bennett, Maitland

Peter Ogden, Maitland

+ 44 (0) 20 7379 5151

 

 

Notes

 

1) Total Impala silo bank debt was ÂŁ1.2 billion as at 31 December 2013. As a result of the partial repayment of Impala silo bank debt following the completion of the Bond issue and the divestment of Ignis Asset Management Limited, together with amortisation payments made during the first half of 2014, the outstanding Impala bank debt will be ÂŁ0.6 billion on a pro forma basis as at 30 June 2014. In addition there is ÂŁ0.4 billion of outstanding Pearl silo bank debt and PIK notes and ÂŁ0.1 billion of Impala PIK notes as at 30 June 2014.

2) The net proceeds of the Bond issue will be used to reduce the Impala silo bank debt, which includes debt owed to certain of the joint lead managers (HSBC and Lloyds Bank) who are lenders under the Impala facility.

3) Phoenix is the UK's largest specialist consolidator of closed life funds with over 5 million policyholders as at 31 December 2013.

 

 

 

 

Disclaimer

 

This announcement is for information purposes only and does not contain or constitute an offer of, or the solicitation of an offer to buy, securities to any person in the United States or in any other jurisdiction, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No offer or sale of any securities referred to herein has been or will be registered under the Securities Act. There will be no public offer of any such securities in the United States.

 

This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the Directive 2010/73/EU of the Parliament and Council of November 4, 2003 as implemented by the Member States of the European Economic Area (the "Prospectus Directive"). The offer and sale of the Bond was made pursuant to an exemption under the Prospectus Directive, as implemented in Member States of the European Economic Area, from the requirement to produce a prospectus for offers of securities.

 

This communication is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments or (iii) are persons falling within Article 49 (2(a) to (d) ("high net worth companies, unincorporated associations etc") of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons together being referred to as "relevant persons"). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRKMGFVVGDGDZM
Date   Source Headline
10th Apr 20249:43 amRNSDirector/PDMR Shareholding
9th Apr 20248:33 amRNSDirector/PDMR Shareholding
8th Apr 20242:15 pmRNSNotice of AGM
3rd Apr 20241:02 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:26 pmRNSTotal Voting Rights
2nd Apr 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20245:40 pmRNSDirector/PDMR Shareholding
27th Mar 20244:20 pmRNSAnnual Financial Report
27th Mar 20242:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNS2023 Annual Financial Report
6th Mar 20242:00 pmRNSDirector/PDMR Shareholding
1st Mar 20249:35 amRNSTotal Voting Rights
6th Feb 20245:17 pmRNSDirector/PDMR Shareholding
2nd Feb 202410:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNS2023 Trading Statement
8th Jan 20245:09 pmRNSDirector/PDMR Shareholding
2nd Jan 20243:15 pmRNSTotal Voting Rights
11th Dec 20236:13 pmRNSBlock listing Interim Review
6th Dec 20234:28 pmRNSDirector/PDMR Shareholding
5th Dec 202311:42 amRNSFinal Result of Tender Offer
5th Dec 202310:22 amRNSIndicative Result of Tender Offer
5th Dec 20237:10 amRNSPublication of Final Terms
1st Dec 202311:46 amRNSTotal Voting Rights
28th Nov 20235:46 pmRNSIssue of Debt and Tender Maximum Acceptance Amount
27th Nov 20238:20 amRNSTender Offers and New Issue
24th Nov 202311:05 amRNSDirector Declaration
23rd Nov 20232:00 pmRNSPublication of Supplementary Prospectus
23rd Nov 202310:00 amRNSDirectorate Change
13th Nov 20237:00 amRNSUpgrade of near-term cash generation targets
7th Nov 20235:10 pmRNSDirector/PDMR Shareholding
1st Nov 20232:07 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20231:17 pmRNSDirector/PDMR Shareholding
25th Oct 20231:16 pmRNSDirector/PDMR Shareholding
9th Oct 202312:40 pmRNSDirector/PDMR Shareholding
9th Oct 202311:20 amRNSDirector/PDMR Shareholding
4th Oct 202310:00 amRNSBoard Changes
2nd Oct 20233:00 pmRNSPublication of Supplementary Prospectus
2nd Oct 20231:35 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20232:46 pmRNSDirector/PDMR Shareholding
28th Sep 202312:49 pmRNSAvailability of Interim Financial Report
28th Sep 20237:00 amRNSInterim Financial Report
18th Sep 20237:00 amRNS2023 Interim Results
14th Sep 202310:00 amRNSHY23 reporting update
8th Sep 20239:33 amRNSDirector/PDMR Shareholding
1st Sep 20231:29 pmRNSTotal Voting Rights
9th Aug 20235:04 pmRNSDirector/PDMR Shareholding
1st Aug 20233:16 pmRNSTotal Voting Rights
7th Jul 20233:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.